Clinical Trials

Carcinoma, Intraductal, Noninfiltrating

NCT07149857 2026-04-13

CARTITUDE-10

60 enrolled

Plasma cell

Multiple Myeloma

NCT04031677 2026-03-31

STRASS2

250 enrolled

Sarcoma

Leiomyosarcoma, Liposarcoma

NCT06788912 2026-03-31

MK-3475-01E

Phase EARLY_PHASE1 Active not recruiting

60 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT03387553 2026-03-27

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT07498959 2026-03-27

TESTIGO

Phase 3 Active not recruiting

160 enrolled

Genitourinary

Testicular Neoplasms, Seminoma

NCT02089100 2026-03-19

STEREO-SEIN

154 enrolled

Breast Neoplasms

NCT03519412 2026-03-03

ARETHUSA

Phase 2 Completed

107 enrolled 14 charts

Colorectal Neoplasms, Microsatellite Instability

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT05544136 2026-02-27

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07033819 2026-02-27

Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib

Phase NA Active not recruiting

48 enrolled

Gynecologic

Ovarian Neoplasms

NCT06587451 2026-02-24

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Phase 3 Terminated

52 enrolled

Dermatologic

Melanoma

NCT03978663 2026-02-20

TRIO

40 enrolled

High-Risk Cancer

NCT06290687 2026-02-18

Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy

Phase 1/2 Not yet recruiting

40 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Phase NA Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07407244 2026-02-17

AKRA

268 enrolled

Phase NA Not yet recruiting

Breast Neoplasms

NCT07413146 2026-02-17

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

100 enrolled

Phase 4 Active not recruiting

Colonic Neoplasms, Neoplasm, Residual

NCT02875314 2026-02-12

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

250 enrolled

CNS

Medulloblastoma

NCT02212860 2026-02-11

SIGNAL 2

Phase NA Completed

139 enrolled

Tumor-Agnostic

Neoplasms

NCT05412225 2026-02-11

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Phase 1 Recruiting

60 enrolled

Breast Neoplasms

NCT06107920 2026-02-10

COnCERTO

232 enrolled

Phase EARLY_PHASE1 Active not recruiting

Colonic Neoplasms

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

34 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06386887 2026-02-09

Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer

20 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Intermittent Fasting

NCT06417190 2026-02-04

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

20 enrolled

Tumor-Agnostic

Neoplasms

NCT06739655 2026-02-04

PRADAIIBE

180 enrolled

Breast Neoplasms, Neoplasms

NCT07383818 2026-02-03

Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)

111 enrolled

Breast Neoplasms

NCT07385001 2026-02-03

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Phase 1/2 Recruiting

45 enrolled

Esophageal Squamous Cell Carcinoma

NCT04495088 2026-02-02

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

550 enrolled

Rectal Neoplasms

NCT07370337 2026-01-27

Induction Chemotherapy Combined With Tislelizumab for Locally Advanced Squamous Cell Carcinoma of the External Auditory Canal

50 enrolled

Squamous Cell Carcinoma of External Auditory Canal

NCT07353723 2026-01-20

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

10 enrolled

Head & Neck

Pathologic Complete Response, Head and Neck Neoplasms

NCT02296684 2026-01-15

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

67 enrolled 15 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06660810 2026-01-15

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

2 enrolled

Sarcoma

NCT07103395 2026-01-14

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

56 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06498154 2025-12-19

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

200 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT07038122 2025-12-18

RESET

874 enrolled

Locally Advanced Rectal Carcinoma

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

35 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT05659251 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

48 enrolled

Esophageal Squamous Cell Carcinoma

NCT05882513 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

Phase 2 Not yet recruiting

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07244978 2025-12-02

Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

49 enrolled

Phase 2 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT07259122 2025-12-02

ZBR in WM

43 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT07254858 2025-11-28

CISN-L

Phase 2 Not yet recruiting

302 enrolled

Breast Neoplasms

NCT03926338 2025-11-20

PICC

270 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT07236320 2025-11-19

Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC

Phase NA Completed

200 enrolled

Esophageal Squamous Cell Carcinoma

NCT04209790 2025-11-10

NeoGlio

Phase 2 Terminated

2 enrolled 7 charts

CNS

Glioblastoma, Glioma

NCT00462696 2025-10-06

ISNA-Sein

Phase NA Completed

16 enrolled 2 charts

Breast Neoplasms

NCT07202819 2025-10-02

"NAC-MRI"

76 enrolled

Genitourinary

Muscle Invasive Bladder Cancer

NCT00872625 2025-09-30

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Phase 1 Completed

26 enrolled

Breast Neoplasms

NCT04727307 2025-09-30

AB-LATE02

202 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT06601309 2025-09-15

ESCC

90 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06831136 2025-09-10

PANCARDINAL-2